ReviewTherapeutic advances in urology2018

Cabozantinib in the treatment of advanced renal cell carcinoma in adults following prior vascular endothelial growth factor targeted therapy: clinical trial evidence and experience.

Susanne Osanto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.